MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2967/jnumed.125.271332

Медицинская библиотека · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025

SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization.

Rowe Steven P, Shuch Brian M, Ball Mark W, Bex Axel, Javadi Mehrbod S, Klitzke Alan, Goffin Karolien, Mulders Peter, Pandit-Taskar Neeta, Parihar Ashwin Singh, Viglianti Benjamin L, Gorin Michael A, Herrmann Ken

СтатьяКлинические рекомендацииПеревод в очереди

Аннотация

Anatomic imaging of renal masses provides limited information on the histology or likely aggressiveness of the tumor, leading to the use of invasive procedures such as renal mass biopsy or empiric partial or radical nephrectomy. Molecular imaging can assist in risk stratification of indeterminate renal masses, potentially contributing to optimal patient decision-making. Two primary approaches have been explored for renal mass molecular imaging. The first is the use of agents that target carbonic anhydrase IX (CAIX), a cell-surface protein that is over-expressed on clear cell renal cell carcinoma (ccRCC) and generally not expressed on other renal tumors. A recent phase III trial (ZIRCON) is widely believed to have laid the groundwork for United States Food and Drug Administration approval of the CAIX monoclonal antibody 89Zr-girentuximab. The second approach is the use of mitochondrial imaging agents, most notably 99mTc-sestamibi, which are lipophilic cations that accumulate in tumors with an abundance of mitochondria with negative charge potential (e.g., oncocytomas and other benign/indolent lesion) and do not accumulate in tumors with multidrug resistance pumps (e.g., ccRCC). The complementary information from 89Zr-girentuximab and 99mTc-sestamibi can provide improved risk stratification. Further, emerging new targeted radiotracers and techniques such as imaging biomarker discovery with artificial intelligence will bolster those concepts. In this manual, we synthesize key data into a recommended approach.

Для цитирования: Rowe Steven P, Shuch Brian M, Ball Mark W, Bex Axel, Javadi Mehrbod S, Klitzke Alan, Goffin Karolien, Mulders Peter, Pandit-Taskar Neeta, Parihar Ashwin Singh, Viglianti Benjamin L, Gorin Michael A, Herrmann Ken. SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2025. DOI: 10.2967/jnumed.125.271332.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.